DexCom said that on Tuesday it received a warning letter from the U.S. FDA following ... related to concerns about manufacturing processes and quality management systems. The FDA cited issues ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果